Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 70 publications
Sirexatamab in Combination with Bevacizumab and Chemotherapy as Second-Line Therapy for Advanced Colorectal Adenocarcinoma: the Phase II DeFianCe Trial.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: April 23, 2026
ASO Visual Abstract: Practice Patterns of Graduates from a Surgical Oncology Fellowship Program.
Journal: Annals of surgical oncology
Published: February 20, 2026
Design and preliminary report of a randomized phase IIb clinical trial of multitargeted recombinant adenovirus 5 vaccines against CEA, MUC1, and brachyury (Tri-Ad5) and the IL-15 receptor superagonist nogapendekin alfa inbakicept in Lynch syndrome (TRIAD5-Plus): the first cross-network trial of the Cancer Prevention Clinical Trials Network (CP-CTNet).
Journal: Frontiers in immunology
Published: February 11, 2026
FOLFOXIRI plus panitumumab for left-sided RAS-wild-type metastatic colorectal cancer.
Journal: The oncologist
Published: November 10, 2025
Genomic analysis of oesophageal carcinoma (EC) identifies recurrent mutations in histone methyltransferases as a distinctive subset.
Journal: Oncogene
Published: November 05, 2025
Dosimetry Results from the Phase 1b/3 ACTION-1 Trial of [225Ac]Ac-DOTATATE (RYZ101) in Patients with Somatostatin Receptor-Expressing, Well-Differentiated GEP-NETs.
Journal: Journal of nuclear medicine : official publication, Society of Nuclear Medicine
Published: June 26, 2025
Phase II Clinical Trial and Preclinical Evaluation of a Novel CD47 Blockade Combination in Refractory Microsatellite-Stable Metastatic Colorectal Cancer.
Journal: Cancer research communications
Published: June 18, 2025
Practice Patterns of Graduates from a Surgical Oncology Fellowship Program.
Journal: Annals of surgical oncology
Published: June 04, 2025
Unveiling ctDNA Response: Immune Checkpoint Blockade Therapy in a Patient with POLE Mutation-Associated Early-Onset Colon Cancer.
Journal: Current oncology (Toronto, Ont.)
Published: May 08, 2025
Perioperative therapy for resectable and borderline resectable pancreatic adenocarcinoma: an Academic Gastrointestinal Cancer Consortium Study.
Journal: The oncologist
Published: March 19, 2025
Reply to: Should Total Neoadjuvant Therapy Be the First-Line Treatment for Patients With Locally Advanced Rectal Cancer?
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: January 06, 2025
Last Updated: 09/26/2026